about
Drug Induced Steatohepatitis: An Uncommon Culprit of a Common DiseaseJaundice and hepatorenal syndrome associated with cytosine arabinosideFulminant hepatic failure induced by lamotrigineIncidence, characteristics and risk factors of adverse drug reactions in hospitalized children - a prospective observational cohort study of 6,601 admissions.High-flux hemodialysis without hemoperfusion is effective in acute valproic acid overdose.Protective effects of fennel oil extract against sodium valproate-induced hepatorenal damage in albino rats.Diagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatments.Molecular pharmacology in a simple model system: implicating MAP kinase and phosphoinositide signalling in bipolar disorder.Psychiatric treatment considerations with direct acting antivirals in hepatitis CValproic Acid and Hepatic Steatosis: A Possible Link? About a Case Report.Use of precision-cut renal cortical slices in nephrotoxicity studies.Valproic acid and nonalcoholic fatty liver disease: A possible association?Non-health care facility anticonvulsant medication errors in the United States.Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.In Silico Modeling for the Prediction of Dose and Pathway-Related Adverse Effects in Humans From In Vitro Repeated-Dose Studies.Valproate-associated hepatotoxicity and its biochemical mechanisms.The risk-benefit ratio of anticonvulsant drugs.Comparative Effect of Divided Doses of Adult Solid and Liquid Oral Formulations of Antiepileptic Drugs in the Management of Pediatric Epilepsy.L-Carnitine supplementation to reverse hyperammonemia in a patient undergoing chronic valproic acid treatment: A case report.Sodium valproate inhibits the movement of secretory vesicles in rat hepatocytes.Fatal deterioration of neurological disease after orthotopic liver transplantation for valproic acid-induced liver damage.Diclofenac enhances proinflammatory cytokine-induced aquaporin-4 expression in cultured astrocyte.Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation.Protocols and Applications of Cellular Metabolomics in Safety Studies Using Precision-Cut Tissue Slices and Carbon 13 NMR.Epigenetic, polymorphic and mutational (Αα167Arg→Lys) contribution to a functionally abnormal fibrinogen.Zinc Deficiency and Oxidative Stress Involved in Valproic Acid Induced Hepatotoxicity: Protection by Zinc and Selenium Supplementation.Oxcarbazepine-induced liver injury after sensitization by valproic acid: a case report.Idiosyncratic Valproic Acid–Induced Hepatotoxicity in a Sickle Cell Patient.Valproic acid induced acute liver injury resulting in hepatic encephalopathy- a case report and literature review
P2860
Q26798157-F4022A36-512A-4CEA-9FF6-ED69076E1F17Q28334491-954150E1-FD85-48A1-94F9-C1AB09A6C77FQ28367927-2712A9FE-E9AC-4871-A447-FA152F0DE8F1Q31143856-4EC17C23-C6C3-4F59-BC62-01E2520F7351Q33334900-270E1580-2C59-4061-9CC7-EB7DB0C96F88Q33632760-B8A3FDD3-351F-407F-AC35-FFA54384E66AQ34459114-3248EAE1-DE00-44E9-8FDB-53B2B923A79FQ34548121-4529FF73-3EA8-481D-ADAA-CEB9014570D6Q34721628-13AFCAC4-11F0-4670-9344-1FF469713619Q37299861-14FC6E05-FFE1-4828-AFA6-D9557DBEFCBFQ38048918-60579BCB-60FB-4486-86C0-379560078D4DQ38505408-AE57B857-A37E-4B53-BBA1-95DFDE3CCDDCQ38662955-B03BCBA2-97A6-46D8-923A-80DFE24CBCE0Q38682728-68B7546A-515D-4CC5-8006-3097BC89072DQ38831372-18A4E75E-FFF1-4351-8FFF-467A55C5C1F7Q39602947-AF65DA05-EC6D-46F5-9A30-EF943DB2325EQ39675361-E3A046ED-531C-42C5-A27D-10838C5550A6Q40963082-04CAA638-7077-4C55-AE7E-883C872234E9Q41864413-4341166A-FF2F-4999-A592-0B291ED6EF54Q42842141-6015D207-7F10-4ADD-BEE0-87E8EB9C2565Q43505918-953B983C-ABCC-40B5-BB3A-CBDC11648F1EQ45280620-849875E3-7042-44DF-991E-5DC0F0B145D2Q46265462-C42F3444-C085-4E82-88CB-2A93D3DAEE03Q47750040-5868A45E-2D3E-46A5-97D6-924E09023A89Q50310711-9545EC6B-FB83-414A-885B-8AA990CED59AQ51168159-0F75B1F1-6B6A-417B-9F66-3EBB946C6DF5Q54495014-CB6390EA-5C5A-4419-960A-9B12566D737CQ55411706-7FC7E0E0-F47C-405F-A39F-A6D8FDE787DFQ57814899-34A23740-D98C-4C6F-AA2B-3C7C8CEAC7B9
P2860
description
1984 nî lūn-bûn
@nan
1984 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Hepatotoxicity to sodium valproate: a review.
@ast
Hepatotoxicity to sodium valproate: a review.
@en
Hepatotoxicity to sodium valproate: a review.
@nl
type
label
Hepatotoxicity to sodium valproate: a review.
@ast
Hepatotoxicity to sodium valproate: a review.
@en
Hepatotoxicity to sodium valproate: a review.
@nl
prefLabel
Hepatotoxicity to sodium valproate: a review.
@ast
Hepatotoxicity to sodium valproate: a review.
@en
Hepatotoxicity to sodium valproate: a review.
@nl
P2093
P2860
P356
P1433
P1476
Hepatotoxicity to sodium valproate: a review.
@en
P2093
J M Tredger
P R Powell-Jackson
R Williams
P2860
P304
P356
10.1136/GUT.25.6.673
P407
P577
1984-06-01T00:00:00Z